Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease

PURPOSE OF REVIEW: We review the growing clinical evidence that metabolic acidosis mediates chronic kidney disease (CKD) progression and that treatment to increase the associated low serum bicarbonate (HCO(3)) in CKD is disease-modifying. RECENT FINDINGS: Seven prospective studies of patients with w...

Descripción completa

Detalles Bibliográficos
Autores principales: Goraya, Nimrit, Wesson, Donald E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
EPIDEMIOLOGY AND PREVENTION: Edited by Navdeep Tangri
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467553/
https://www.ncbi.nlm.nih.gov/pubmed/30681417
http://dx.doi.org/10.1097/MNH.0000000000000491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467553/
https://www.ncbi.nlm.nih.gov/pubmed/30681417
http://dx.doi.org/10.1097/MNH.0000000000000491

Ejemplares similares